Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.63 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30657716 | 1.00 | BACE1 (0.63) | BACE1ARHSP90AA1NPC1MEN1 | |
| SCHEMBL57528 | 0.79 | CCR1 (0.43) | BACE1HSP90AA1RAB9ALMNAKDM4E | |
| SCHEMBL5763166 | 0.77 | BACE1 (0.59) | BACE1ARHSP90AA1NPC1MEN1 | |
| SCHEMBL340255 | 0.77 | METAP2 (0.59) | BACE1ARMEN1KMT2ARAB9A | |
| SCHEMBL1030675 | 0.77 | BACE1 (0.64) | BACE1ARHSP90AA1NPC1MEN1 | |
| SCHEMBL15228915 | 0.77 | BACE1 (1.00) | BACE1PLAUNCF1 | |
| SCHEMBL16535454 | 0.77 | BACE1 (0.59) | BACE1ARHSP90AA1NPC1MEN1 | |
| SCHEMBL4134465 | 0.77 | BACE1 (0.59) | BACE1ARHSP90AA1NPC1MEN1 | |
| SCHEMBL22119746 | 0.77 | BACE1 (0.48) | BACE1HSP90AA1NPC1MEN1KMT2A | |
| SCHEMBL3850693 | 0.77 | XPO1 (0.41) | BACE1ARHSP90AA1NPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110041905-B | Fluorescent and phosphorescent dual luminescent material with switching effect and preparation method thereof | 华中科技大学 | 2020-05-19 | — | — | CN | claimed |
| EP-4701783-A1 | PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4701782-A1 | CATALYST SYSTEM AND ETHYLENE OLIGOMERIZATION PROCESS FOR THE PREPARATION OF LINEAR ALPHA OLEFINS | Chevron Phillips Chemical Company LP (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20240400473-A1 | CATALYST SYSTEM AND ETHYLENE OLIGOMERIZATION PROCESS FOR THE PREPARATION OF LINEAR ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2024-12-05 | — | — | US | disclosed |
| US-20240360052-A1 | PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2024-10-31 | — | — | US | disclosed |
| WO-2024226497-A1 | CATALYST SYSTEM AND ETHYLENE OLIGOMERIZATION PROCESS FOR THE PREPARATION OF LINEAR ALPHA OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024226492-A1 | PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-118271332-A | Organic compound and display panel | 武汉华星光电半导体显示技术有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-117024419-A | Chiral 2-oxazoline-8-imine quinoline compound and metal complex thereof, preparation method and application | 浙江大学 | 2023-11-10 | — | — | CN | disclosed |
| US-11198745-B2 | Poly(alpha-olefin)s and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-14 | — | — | US | disclosed |
| WO-2011011040-A1 | CATALYSTS BASED ON 2-(2-ARYLOXY) QUINOLINE OR 2-(2-ARYLOXY) DIHYDROQUNIOLINE LIGANDS | EQUISTAR CHEMICALS, LP (US) | 2011-01-27 | — | — | WO | disclosed |
| US-7858718-B1 | Catalysts based on 2-aryl-8-anilinoquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858718-B1 | Catalysts based on 2-aryl-8-anilinoquinoline ligands | EQUISTAR CHEMICALS, LP (US) | 2010-12-28 | — | — | US | disclosed |
| US-20100144751-A1 | IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2010-06-10 | — | — | US | disclosed |
| WO-2010022081-A1 | TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| US-20100029633-A1 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2010-02-04 | — | — | US | disclosed |
| EP-2139888-A2 | IMIDAZOÝ1,2-A¨PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2010-01-06 | — | — | EP | disclosed |
| EP-2137184-A1 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008124323-A1 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008121687-A2 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029633-A1 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | PIM1, PIM3, PIM2 | BACE1 4126/4885AR 1091/4885HSP90AA1 3229/4885 |
| US-20240360052-A1 | PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES | PHOSPHO1, PEBP1, PPIP5K2 | BACE1 2471/4885AR 4752/4885HSP90AA1 4697/4885 |
| US-20100144751-A1 | IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS | PIM1, PIM3, PIM2 | BACE1 4467/4885AR 2295/4885HSP90AA1 2155/4885 |
| US-11198745-B2 | Poly(alpha-olefin)s and methods thereof | PUF60, DEGS1, POLL | BACE1 777/4885AR 3349/4885HSP90AA1 1209/4885 |
| US-20240400473-A1 | CATALYST SYSTEM AND ETHYLENE OLIGOMERIZATION PROCESS FOR THE PREPARATION OF LINEAR ALPHA OLEFINS | AP1M1, AP2M1, OXER1 | BACE1 1039/4885AR 2461/4885HSP90AA1 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.